Navina

From a military AI lab to the doctor's office

Navina was founded in 2018 and operates in Israel and New York, according to MedCity News. Its founders, CEO Ronen Lavi and Shay Perera, headed the Israel Defense Forces' AI lab, according to TechCrunch. There, they say, they built assistant systems for analysts who were flooded with information. They carried the same idea over to medicine: a family doctor in the United States receives information about a patient from many sources, such as the electronic health record, insurance claims, pharmacies and wearable devices. The information is scattered and not always in time order, and before each visit the doctor has only a few minutes to make sense of it.

What the tool does

According to TechCrunch, the system plugs into existing electronic health record software. It was trained on documents such as imaging reports, consultation and hospital discharge summaries, procedures and lab tests, in a dataset collected by a team led by doctors. From these, it identifies possible diagnoses and gaps in the quality of care or in risk documentation that need attention. The output is a concise patient profile with insights, shown to the doctor at the point of care. Today the company's website also presents a transcription of the visit conversation, which is combined with the historical information for summaries and documentation.

The context: payment by results

The product is hard to understand without the American value-based care payment model. In this model, a medical organization is paid according to the results of care and the documented risk level of its patients, not according to the number of visits. So a diagnosis that was not documented is both a medical problem and a financial problem. Lavi told MedCity News that many doctors are worried about the documentation demands that come with this model. Among the customers the company lists are large primary care organizations such as Privia Health, agilon health and Millennium Physician Group.

Funding and scale of use

In October 2022 the company raised $22 million, according to TechCrunch. In March 2025 it announced a $55 million Series C round led by the growth equity arm of Goldman Sachs Alternatives, with participation from Vertex Ventures Israel, Grove Ventures and ALIVE. Total funding reached $100 million. In the same announcement the company said the system serves more than 10,000 clinicians at 1,300 clinics and supports the care of more than three million patients. According to the company, 86 percent of users are active every week, and it won the Best in KLAS title for 2025. These are all figures the company provided.

2026 and the open questions

In June 2026 the company's head of human resources described in an interview with CTech how, at the peak of the escalation with Iran, 10 to 20 percent of the Israeli team were serving in the reserves. She also told of an internal task force for bringing AI into the company's own work. As of September 2026 Navina is a private company, and no report of an acquisition was found. The open questions are similar to those facing other automatic medical documentation tools: how far a summary produced by a machine can be trusted, what happens when something important is left out of it, and how bias is handled. As early as 2022 Lavi told TechCrunch that the company takes steps against bias and has passed an outside privacy audit, but these are the company's own statements, not an independent assessment.